<SEC-DOCUMENT>0001193125-17-199142.txt : 20170609
<SEC-HEADER>0001193125-17-199142.hdr.sgml : 20170609
<ACCEPTANCE-DATETIME>20170609072434
ACCESSION NUMBER:		0001193125-17-199142
CONFORMED SUBMISSION TYPE:	6-K
PUBLIC DOCUMENT COUNT:		4
CONFORMED PERIOD OF REPORT:	20170609
FILED AS OF DATE:		20170609
DATE AS OF CHANGE:		20170609

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			NOVOGEN LTD
		CENTRAL INDEX KEY:			0001075880
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		IRS NUMBER:				000000000
		FISCAL YEAR END:			0630

	FILING VALUES:
		FORM TYPE:		6-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	000-29962
		FILM NUMBER:		17901491

	BUSINESS ADDRESS:	
		STREET 1:		LEVEL 5
		STREET 2:		20 GEORGE STREET
		CITY:			HORNSBY NSW
		STATE:			C3
		ZIP:			2077
		BUSINESS PHONE:		01161298780088

	MAIL ADDRESS:	
		STREET 1:		LEVEL 5
		STREET 2:		20 GEORGE STREET
		CITY:			HORNSBY NSW
		STATE:			C3
		ZIP:			2077
</SEC-HEADER>
<DOCUMENT>
<TYPE>6-K
<SEQUENCE>1
<FILENAME>d411991d6k.htm
<DESCRIPTION>FORM 6-K
<TEXT>
<HTML><HEAD>
<TITLE>Form 6-K</TITLE>
</HEAD>
 <BODY BGCOLOR="WHITE">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="line-height:1.0pt;margin-top:0pt;margin-bottom:0pt;border-bottom:1px solid #000000">&nbsp;</P>
<P STYLE="line-height:3.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&nbsp;</P> <P STYLE="margin-top:4pt; margin-bottom:0pt; font-size:18pt; font-family:Times New Roman" ALIGN="center"><B>UNITED STATES </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:18pt; font-family:Times New Roman" ALIGN="center"><B>SECURITIES AND EXCHANGE COMMISSION </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman" ALIGN="center"><B>Washington, D.C. 20549 </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><center>
<P STYLE="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%">&nbsp;</P></center> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:18pt; font-family:Times New Roman" ALIGN="center"><B>Form 6-K
</B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><center> <P STYLE="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%">&nbsp;</P></center>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman" ALIGN="center"><B>REPORT OF FOREIGN PRIVATE ISSUER </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman" ALIGN="center"><B>PURSUANT TO RULE 13a-16 OR 15d-16 </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman" ALIGN="center"><B>UNDER THE SECURITIES EXCHANGE ACT OF 1934 </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>For the month of June, 2017 </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Commission File Number
<U>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</U> </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><center>
<P STYLE="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%">&nbsp;</P></center> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:24pt; font-family:Times New Roman" ALIGN="center"><B>Novogen
Limited </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>(Translation of registrant&#146;s name into English) </B></P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><center> <P STYLE="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%">&nbsp;</P></center>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Level 5, 20 George Street, Hornsby, NSW 2077, Australia </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>(Address of principal executive office) </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><center>
<P STYLE="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%">&nbsp;</P></center> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Indicate by check mark whether
the registrant files or will file annual reports under cover of Form 20-F or Form 40-F. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">Form
20-F&nbsp;&nbsp;&#9745;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Form 40-F&nbsp;&nbsp; &#9744; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Indicate by check mark if
the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(1):&nbsp;&nbsp;&#9744; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Note</B>: Regulation S-T Rule
101(b)(1) only permits the submission in paper of a Form 6-K if submitted solely to provide an attached annual report to security holders. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Indicate by
check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(7):&nbsp;&nbsp;&#9744; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Note</B>:
Regulation S-T Rule 101(b)(7) only permits the submission in paper of a Form 6-K if submitted to furnish a report or other document that the registrant foreign private issuer must furnish and make public under the laws of the jurisdiction in which
the registrant is incorporated, domiciled or legally organized (the registrant&#146;s &#147;home country&#148;), or under the rules of the home country exchange on which the registrant&#146;s securities are traded, as long as the report or other
document is not a press release, is not required to be and has not been distributed to the registrant&#146;s security holders, and, if discussing a material event, has already been the subject of a Form 6-K submission or other Commission filing on
EDGAR. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Indicate by check mark if the registrant by furnishing the information contained in this form is also thereby furnishing the information to the
Commission pursuant to Rule 12g3-2(b) under the Securities Exchange Act of 1934. Yes&nbsp;&nbsp;&#9744;&nbsp;&nbsp;&nbsp;&nbsp; No&nbsp;&nbsp;&#9745; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">If
&#147;yes&#148; is marked, indicate below the file number assigned to the registrant in connection with Rule 12g3-2(b) </P> <P STYLE="font-size:10pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="line-height:1.0pt;margin-top:0pt;margin-bottom:0pt;border-bottom:1px solid #000000">&nbsp;</P> <P STYLE="line-height:3.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&nbsp;</P>

<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>SIGNATURE </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned,
thereunto duly authorized. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Novogen Limited </B>(Registrant) </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><U>Kate Hill </U></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Kate Hill </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Company Secretary </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Date 9 June 2017 </P>

<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0pt;margin-bottom:0pt" ALIGN="center">


<IMG SRC="g411991txpg3a.jpg" ALT="LOGO">
 </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>
<TD WIDTH="19%"></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD WIDTH="79%"></TD></TR>


<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">ASX:NRT</P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">NASDAQ:NVGN</P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Novogen Ltd</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">(Company)</P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">ABN 37 063 259 754</P>
<P STYLE="margin-top:0pt;margin-bottom:0pt;border-bottom:1px solid #000000">&nbsp;</P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Capital Structure</B></P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Ordinary&nbsp;Shares&nbsp;on&nbsp;issue:</P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">483 M</P> <P STYLE="margin-top:0pt;margin-bottom:0pt;border-bottom:1px solid #000000">&nbsp;</P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Board of Directors</B></P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Mr Iain Ross</B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Chairman</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><FONT STYLE="white-space:nowrap">Non-Executive</FONT>
Director</P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Mr Bryce Carmine</B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Deputy Chairman</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><FONT STYLE="white-space:nowrap">Non-Executive</FONT> Director</P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Mr Steven Coffey</B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><FONT STYLE="white-space:nowrap">Non-Executive</FONT> Director</P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Dr James Garner</B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Chief Executive Officer</P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman">Managing Director</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>ASX RELEASE</B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">09 June 2017</P> <P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>NOVOGEN UPDATES SECURITIES TRADING POLICY</B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt" align="left">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Sydney, 09 June 2017 &#150; Australian oncology-focused biotechnology company Novogen Limited (ASX: NRT; NASDAQ: NVGN) has updated its Securities Trading
Policy as part of its annual review of corporate governance processes and documentation.</P> <P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>About Novogen Limited</B></P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Novogen Limited (ASX: NRT; NASDAQ: NVGN) is an emerging oncology-focused biotechnology company, based in Sydney, Australia. Novogen has a portfolio of
development candidates, diversified across several distinct technologies, with the potential to yield <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">first-in-class</FONT></FONT> and <FONT STYLE="white-space:nowrap"><FONT
STYLE="white-space:nowrap">best-in-class</FONT></FONT> agents in a range of oncology indications.</P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The lead program is <FONT STYLE="white-space:nowrap">GDC-0084,</FONT> a small molecule inhibitor of the PI3K / AKT / mTOR pathway, which is being developed to
treat glioblastoma multiforme. Licensed from Genentech in late 2016, <FONT STYLE="white-space:nowrap">GDC-0084</FONT> is anticipated to enter phase II clinical trials in 2017. A second clinical program, <FONT STYLE="white-space:nowrap"><FONT
STYLE="white-space:nowrap">TRXE-002-01</FONT></FONT> (Cantrixil) commenced a phase I clinical trial in ovarian cancer in December 2016. In addition, the company has several preclinical programs in active development, the largest of which is
substantially funded by a <FONT STYLE="white-space:nowrap">CRC-P</FONT> grant from the Australian Federal Government.</P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman">For more information, please visit: <U>www.novogen.com</U></P></TD></TR>
</TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt;margin-bottom:0pt" ALIGN="center">


<IMG SRC="g411991txpg3b.jpg" ALT="LOGO">
 </P>

<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0pt;margin-bottom:0pt; margin-right:43%">


<IMG SRC="g411991g0609170443750.jpg" ALT="LOGO">
 </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="line-height:1.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000">&nbsp;</P>
<P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>
<TD WIDTH="45%"></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD WIDTH="53%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Trading Policy</B></P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Novogen Limited (ACN 063 259 754)</B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>(Company)</B></P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman"><B>Approved by the Board on 9&nbsp;June 2017</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"></TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD></TR>
</TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>
<TD WIDTH="100%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Baker&nbsp;&amp; McKenzie</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">ABN 32 266 778
912</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">AMP Centre</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Level 27</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">50 Bridge Street</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Sydney NSW 2000</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Australia</P> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman">www.bakermckenzie.com</P></TD></TR>
</TABLE>

<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><A NAME="toc"></A>Table of contents </B></P>
<P STYLE="line-height:3.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&nbsp;</P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>
<TD WIDTH="1%"></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD WIDTH="95%"></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>1.</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B><A HREF="#tx411991_1">Purpose</A></B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>2</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>2.</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B><A HREF="#tx411991_2">Insider trading prohibitions in the Corporations Act</A></B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>2</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>3.</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B><A HREF="#tx411991_3">No dealing in Prohibited Periods</A></B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>4</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>4.</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B><A HREF="#tx411991_4">Exceptional circumstances</A></B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>6</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>5.</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B><A HREF="#tx411991_5">Permitted dealings</A></B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>6</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>6.</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B><A HREF="#tx411991_6">Further restrictions</A></B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>7</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>7.</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B><A HREF="#tx411991_7">Confidential Information</A></B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>8</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>8.</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B><A HREF="#tx411991_8">Review and publication of this policy</A></B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>9</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD></TR>
</TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">i </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Trading Policy </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="line-height:1.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000">&nbsp;</P> <P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><B><A NAME="tx411991_1"></A>1.</B></TD>
<TD ALIGN="left" VALIGN="top"><B>Purpose </B></TD></TR></TABLE> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Scope </B></P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">1.1</TD>
<TD ALIGN="left" VALIGN="top">This policy summarises the law relating to insider trading and sets out Company&#146;s trading policy on buying and selling securities of the Company including shares, options and any other financial products of the
Company that are able to be traded on a financial market (<B>Company&#146;s Securities</B>). </TD></TR></TABLE> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Who does this policy apply to? </B></P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">1.2</TD>
<TD ALIGN="left" VALIGN="top">This policy applies as follows: </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(a)</TD>
<TD ALIGN="left" VALIGN="top">part 2 (insider trading laws) and part 7 (confidentiality) apply to everyone (including all directors, officers, employees, contractors, family and associates); </TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(b)</TD>
<TD ALIGN="left" VALIGN="top">parts 3 to 6 (trading policy) apply to all directors, officers and other key management personnel of the Company along with any other person designated by the board of directors (<B>Board</B>) (each a <B>Designated
Person</B>); and </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(c)</TD>
<TD ALIGN="left" VALIGN="top">paragraphs 3.11 to 3.12 (associates) applies certain aspects of our trading policy to the family and associates of Designated Persons as specified in that paragraph. </TD></TR></TABLE>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Further advice </B></P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">1.3</TD>
<TD ALIGN="left" VALIGN="top">If you do not understand any aspect of this trading policy, or are uncertain whether it applies to you or your family or associates, please contact the Chief Executive Officer or Company Secretary. You may wish to
obtain your own legal or financial advice before dealing in the Company&#146;s Securities. </TD></TR></TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="line-height:1.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000">&nbsp;</P> <P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><B><A NAME="tx411991_2"></A>2.</B></TD>
<TD ALIGN="left" VALIGN="top"><B>Insider trading prohibitions in the Corporations Act </B></TD></TR></TABLE> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>What are the insider trading prohibitions?
</B></P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">2.1</TD>
<TD ALIGN="left" VALIGN="top">Under the Corporations Act 2001 (Cth) (<B>Corporations Act</B>), if you have Inside Information (as defined in paragraphs 2.6 to 2.9) relating to the Company it is illegal for you to: </TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(a)</TD>
<TD ALIGN="left" VALIGN="top">deal in (that is, apply for, acquire or dispose of) the Company&#146;s Securities or enter into an agreement to do so; or </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(b)</TD>
<TD ALIGN="left" VALIGN="top">procure another person to apply for, acquire or dispose of the Company&#146;s Securities or enter into an agreement to do so; or </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(c)</TD>
<TD ALIGN="left" VALIGN="top">directly or indirectly communicate, or cause to be communicated, that information to any other person if you know, or ought reasonably to know, that the person would or would be likely to use the information to engage
in the activities specified in paragraphs (a)&nbsp;or (b) above. </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">2.2</TD>
<TD ALIGN="left" VALIGN="top">These prohibitions also apply to the application for, grant, exercise or transfer of an option over the Company&#146;s Securities, and to the Securities of other entities if you possess Inside Information about those
entities. </TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">2 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">2.3</TD>
<TD ALIGN="left" VALIGN="top">It does not matter how or in what capacity you become aware of the Inside Information. It does not have to be obtained from the Company to constitute Inside Information. </TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">2.4</TD>
<TD ALIGN="left" VALIGN="top">You cannot avoid the insider trading prohibition by arranging for a member of your family or a friend to deal in the Company&#146;s Securities nor may you give &#147;tips&#148; concerning Inside Information relating to
the Company to others, including customers. </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">2.5</TD>
<TD ALIGN="left" VALIGN="top">These prohibitions apply to everyone (not just Designated Persons) at all times. </TD></TR></TABLE> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>What is Inside
Information? </B></P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">2.6</TD>
<TD ALIGN="left" VALIGN="top">&#147;<B>Inside Information</B>&#148; is information relating to the Company which is not generally available but, if the information were generally available, would be likely to have a material effect on the price or
value of the Company&#146;s Securities. </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">2.7</TD>
<TD ALIGN="left" VALIGN="top">Inside Information can include matters of speculation or supposition and matters relating to intentions or likely intentions of a person. </TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">2.8</TD>
<TD ALIGN="left" VALIGN="top">Information is regarded as being likely to have a material effect if it would, or would be likely to, influence persons who commonly invest in securities or other traded financial products in deciding whether or not to
deal in the Company&#146;s Securities. </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">2.9</TD>
<TD ALIGN="left" VALIGN="top">Examples of Inside Information could be: </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(a)</TD>
<TD ALIGN="left" VALIGN="top">the financial performance of the Company against its budget; </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(b)</TD>
<TD ALIGN="left" VALIGN="top">changes in the Company&#146;s actual or anticipated financial condition or business performance; </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(c)</TD>
<TD ALIGN="left" VALIGN="top">changes in the capital structure of the Company, including proposals to raise additional equity or borrowings; </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(d)</TD>
<TD ALIGN="left" VALIGN="top">proposed changes in the nature of the business of the Company; </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(e)</TD>
<TD ALIGN="left" VALIGN="top">changes to the Board or significant changes in key management personnel; </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(f)</TD>
<TD ALIGN="left" VALIGN="top">an undisclosed significant change in the Company&#146;s market share; </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(g)</TD>
<TD ALIGN="left" VALIGN="top">likely or actual entry into, or loss of, a material contract; </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(h)</TD>
<TD ALIGN="left" VALIGN="top">material acquisitions or sales of assets by the Company; </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(i)</TD>
<TD ALIGN="left" VALIGN="top">a proposed dividend or other distribution or a change in dividend policy; or </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(j)</TD>
<TD ALIGN="left" VALIGN="top">a material claim against the Company or other unexpected liability. </TD></TR></TABLE> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>When is information generally
available? </B></P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">2.10</TD>
<TD ALIGN="left" VALIGN="top">Information is generally available if: </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(a)</TD>
<TD ALIGN="left" VALIGN="top">it consists of readily observable matter or deductions; </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(b)</TD>
<TD ALIGN="left" VALIGN="top">it has been brought to the attention of investors through an announcement to ASX Limited (<B>ASX</B>) or otherwise similarly brought to the attention of investors who commonly invest in securities, and a reasonable
period has elapsed since it was announced or brought to investors&#146; attention; or </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(c)</TD>
<TD ALIGN="left" VALIGN="top">it consists of deductions, conclusions or inferences made or drawn from information referred to in paragraphs (a)&nbsp;or (b) above. </TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">3 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">2.11</TD>
<TD ALIGN="left" VALIGN="top">Examples of possible readily observable matters are: </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(a)</TD>
<TD ALIGN="left" VALIGN="top">a change in legislation which will affect the Company&#146;s ability to make certain types of investments; or </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(b)</TD>
<TD ALIGN="left" VALIGN="top">a severe downturn in global securities markets. </TD></TR></TABLE> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Penalties </B></P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">2.12</TD>
<TD ALIGN="left" VALIGN="top">Breach of the insider trading laws may subject you to: </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(a)</TD>
<TD ALIGN="left" VALIGN="top">criminal liability - penalties include heavy fines and imprisonment; </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(b)</TD>
<TD ALIGN="left" VALIGN="top">civil liability - you can be sued by another party or the Company for any loss suffered as a result of illegal trading activities; </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(c)</TD>
<TD ALIGN="left" VALIGN="top">civil penalty provisions - the Australian Securities and Investments Commission (<B>ASIC</B>) may seek civil penalties against you and may even seek a court order that you be disqualified from managing a corporation.
</TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">2.13</TD>
<TD ALIGN="left" VALIGN="top">Breach of the law, this policy, or both, will also be regarded by the Company as serious misconduct which may lead to disciplinary action or dismissal. </TD></TR></TABLE>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="line-height:1.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000">&nbsp;</P> <P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><B><A NAME="tx411991_3"></A>3.</B></TD>
<TD ALIGN="left" VALIGN="top"><B>No dealing in Prohibited Periods </B></TD></TR></TABLE> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Closed and Prohibited Periods </B></P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">3.1</TD>
<TD ALIGN="left" VALIGN="top">Designated Persons must not deal in the Company&#146;s Securities during the following prohibited periods (except in accordance with this policy): </TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(a)</TD>
<TD ALIGN="left" VALIGN="top">the following closed periods: </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="8%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(i)</TD>
<TD ALIGN="left" VALIGN="top">from the day after the half year end (i.e. approximately 1 January) to the close of trading on the business day after the Company&#146;s half yearly results are announced to ASX; </TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="8%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(ii)</TD>
<TD ALIGN="left" VALIGN="top">from the day after the financial year end (i.e. approximately 1 July) to the close of trading on the business day after the Company&#146;s annual results are announced to ASX; </TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="8%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(iii)</TD>
<TD ALIGN="left" VALIGN="top">from 28 days before, to the close of trading on the business day after, the Company&#146;s annual general meeting; and </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="8%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(iv)</TD>
<TD ALIGN="left" VALIGN="top">from 28 days before a prospectus or similar disclosure document is lodged by the Company with ASX; and </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(b)</TD>
<TD ALIGN="left" VALIGN="top">any extension to a closed period, and any additional period, as specified by the Board, </TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">(<B>Prohibited Periods</B>). </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">3.2</TD>
<TD ALIGN="left" VALIGN="top">Designated Persons may deal in the Company&#146;s Securities at other times subject to complying with insider trading prohibitions (see part 2 above) and the requirements of this policy. </TD></TR></TABLE>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Prior notification </B></P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">3.3</TD>
<TD ALIGN="left" VALIGN="top">If a Designated Person proposes to deal in the Company&#146;s Securities (including entering into an agreement to deal) at any time they must first provide: </TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(a)</TD>
<TD ALIGN="left" VALIGN="top">written notice of their intention to: </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="8%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(i)</TD>
<TD ALIGN="left" VALIGN="top">the Company Secretary; and </TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">4 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="8%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(ii)</TD>
<TD ALIGN="left" VALIGN="top">the notification officer who is: </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="13%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(A)</TD>
<TD ALIGN="left" VALIGN="top">Chairperson of the Board for all directors and alternate directors of the Company (other than the chairperson of the Board), the Chief Executive Officer and the Company Secretary; </TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="13%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(B)</TD>
<TD ALIGN="left" VALIGN="top">Chief Executive Officer for the Chairperson of the Board; and </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="13%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(C)</TD>
<TD ALIGN="left" VALIGN="top">Company Secretary for all other Designated Persons (<B>Notification Officer</B>); and </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(b)</TD>
<TD ALIGN="left" VALIGN="top">confirmation that you are not in possession of Inside Information. The relevant Notification Officer may appoint a delegate to act on his or her behalf in the case of temporary absence. </TD></TR></TABLE>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Confirmation </B></P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">3.4</TD>
<TD ALIGN="left" VALIGN="top">Before dealing in the Company&#146;s Securities, the Designated Person must receive a confirmation signed by the Notification Officer. The Notification Officer must provide a copy of the signed confirmation to the
Company Secretary. </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">3.5</TD>
<TD ALIGN="left" VALIGN="top">A confirmation expires ten days from its date or on the commencement of a Prohibited Period (whichever is earlier), unless the confirmation specifies a different expiry date. </TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">3.6</TD>
<TD ALIGN="left" VALIGN="top">A confirmation confirms that the proposed dealing by Designated Person is within the terms of the trading policy but does not otherwise constitute approval or endorsement by the Company or the Notification Officer for
the proposed dealing. Even if a confirmation is granted, a Designated Person remains personally responsible for assessing whether the insider trading prohibitions apply to them. </TD></TR></TABLE>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Notification of dealing </B></P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">3.7</TD>
<TD ALIGN="left" VALIGN="top">In addition to providing advance notice under paragraph 3.3, Designated Persons must confirm in writing to the relevant Notification Officer and the Company Secretary, within three business days from when the dealing in
the Company&#146;s Securities has occurred, the number of the Company&#146;s Securities affected and the relevant parties to the dealing. </TD></TR></TABLE>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Register </B></P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">3.8</TD>
<TD ALIGN="left" VALIGN="top">A register of notifications and clearances is to be kept by the Company Secretary. </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">3.9</TD>
<TD ALIGN="left" VALIGN="top">A register of Designated Persons&#146; interests in the Company&#146;s securities is to be kept by the Company Secretary. </TD></TR></TABLE>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Securities of other entities </B></P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">3.10</TD>
<TD ALIGN="left" VALIGN="top">The Board may extend this policy by specifying that Designated Persons are also restricted from dealing in the securities of other specified entities with which the Company may have a close relationship.
</TD></TR></TABLE> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Associates </B></P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">3.11</TD>
<TD ALIGN="left" VALIGN="top">This policy also applies to associates of Designated Persons, except for paragraphs 3.3 to 3.7 regarding prior notification, confirmation and notification of dealing. A Designated Person must communicate on behalf of
their associate with the Notification Officer for the purposes of this policy. </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">3.12</TD>
<TD ALIGN="left" VALIGN="top">&#147;Associates&#148; of a Designated Person includes their family members, trusts, companies, nominees and other persons over whom a Designated Person has, or may be expected to have, investment control or influence.
If you are in doubt as to whether a person is an associate, you should contact the Company Secretary who will make a determination on the issue. </TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">5 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="line-height:1.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000">&nbsp;</P> <P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><B><A NAME="tx411991_4"></A>4.</B></TD>
<TD ALIGN="left" VALIGN="top"><B>Exceptional circumstances </B></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">4.1</TD>
<TD ALIGN="left" VALIGN="top">A Designated Person may request, and the Notification Officer may give, prior confirmation for the Designated Person to: </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(a)</TD>
<TD ALIGN="left" VALIGN="top">deal in the Company&#146;s Securities during a Prohibited Period; or </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(b)</TD>
<TD ALIGN="left" VALIGN="top">dispose of the Company&#146;s Securities even if otherwise prohibited under part 6, </TD></TR></TABLE> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">if there
are exceptional circumstances (except if this would breach the insider trading prohibitions - see part 2 above). </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">4.2</TD>
<TD ALIGN="left" VALIGN="top">Exceptional circumstances may include: </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(a)</TD>
<TD ALIGN="left" VALIGN="top">severe financial hardship, for example, a pressing financial commitment that cannot be satisfied otherwise than by selling the relevant Company&#146;s Securities; </TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(b)</TD>
<TD ALIGN="left" VALIGN="top">requirements under a court order or court enforceable undertakings or other legal or regulatory requirements; </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(c)</TD>
<TD ALIGN="left" VALIGN="top">other exceptional circumstances as determined by the Chairperson (or Chief Executive Officer where the Chairperson is involved). </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">4.3</TD>
<TD ALIGN="left" VALIGN="top">If the Notification Officer has any doubt in making a determination of exceptional circumstances, they should exercise the discretion with caution. </TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">4.4</TD>
<TD ALIGN="left" VALIGN="top">The requirements of paragraphs 3.3 to 3.7 must be complied with regarding prior notification, confirmation and notification of dealing. </TD></TR></TABLE>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="line-height:1.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000">&nbsp;</P> <P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><B><A NAME="tx411991_5"></A>5.</B></TD>
<TD ALIGN="left" VALIGN="top"><B>Permitted dealings </B></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">5.1</TD>
<TD ALIGN="left" VALIGN="top">The following types of dealing are excluded from the operation of part 3 and part 6.2 (as applicable) of this policy and may be undertaken at any time without requiring prior notification, approval or confirmation of
dealing, subject to the insider trading prohibitions: </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(a)</TD>
<TD ALIGN="left" VALIGN="top">(<B>superannuation</B>) transfers of the Company&#146;s Securities which are already held in a superannuation fund or other saving scheme in which the Designated Person is a beneficiary; </TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(b)</TD>
<TD ALIGN="left" VALIGN="top">(<B>third parties</B>) an investment in, or trading in units of, a fund or other scheme (other than a scheme only investing in the Company&#146;s Securities) where the assets of the fund or other scheme are invested at
the discretion of a third party; </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(c)</TD>
<TD ALIGN="left" VALIGN="top">(<B>other trustees</B>) where a Designated Person is a trustee, trading in the Company&#146;s Securities by the respective trust provided the Designated Person is not a beneficiary of the trust and any decision to trade
during a Prohibited Period is taken by the other trustees or by the investment managers independently of the Designated Person; </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(d)</TD>
<TD ALIGN="left" VALIGN="top">(<B>takeover</B>) undertakings to accept, or the acceptance of, a takeover offer; </TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">6 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(e)</TD>
<TD ALIGN="left" VALIGN="top">(<B>rights offers, SPPs, DRPs and <FONT STYLE="white-space:nowrap">buy-backs</FONT></B>) trading under an offer or invitation made to all or most of the security holders, such as a rights issue, a security purchase
plan, a dividend or distribution reinvestment plan and an equal access <FONT STYLE="white-space:nowrap">buy-back,</FONT> where the plan that determines the timing and structure of the offer has been approved by the Board. This includes decisions
relating to whether or not to take up the entitlements and the sale of entitlements required to provide for the take up of the balance of entitlements under a renounceable pro rata issue; </TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(f)</TD>
<TD ALIGN="left" VALIGN="top">(<B>lender disposal</B>) a disposal of the Company&#146;s Securities that is the result of a secured lender (or financier) exercising their rights; </TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(g)</TD>
<TD ALIGN="left" VALIGN="top">(<B>incentive scheme</B>) the exercise (but not the sale of the Company&#146;s Securities following exercise) of an option or right, or the receipt of the Company&#146;s Securities, under an employee incentive scheme,
or the conversion of a convertible security, where the final date for the exercise of the option or right, or the conversion of the security, falls during a Prohibited Period and the Company has been in an exceptionally long Prohibited Period or the
Company has had a number of consecutive Prohibited Periods and the Designated Person could not reasonably have been expected to exercise it at a time when free to do so; and </TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(h)</TD>
<TD ALIGN="left" VALIGN="top">(<B>trading plan</B>) trading under a <FONT STYLE="white-space:nowrap">non-discretionary</FONT> trading plan for which prior written clearance has been provided in accordance with procedures set out in this policy and
where: </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="8%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(i)</TD>
<TD ALIGN="left" VALIGN="top">the Designated Person did not enter into the plan or amend the plan during a Prohibited Period; and </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="8%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(ii)</TD>
<TD ALIGN="left" VALIGN="top">the trading plan does not permit the Designated Person to exercise any influence or discretion over how, when, or whether to trade. </TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:8%; font-size:10pt; font-family:Times New Roman">However, this policy does not allow the Designated Person to cancel the trading plan or cancel or otherwise vary the terms of their
participation in the trading plan during a Prohibited Period other than in exceptional circumstances; </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(i)</TD>
<TD ALIGN="left" VALIGN="top">(<B>dividend reinvestment plan</B>) acquiring the Company&#146;s Securities under a bonus issue made to all holders of the Company&#146;s Securities of the same class; </TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(j)</TD>
<TD ALIGN="left" VALIGN="top">(<B>bonus issues</B>) acquiring the Company&#146;s Securities under a bonus issue made to all holders of the Company&#146;s Securities of the same class; </TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(k)</TD>
<TD ALIGN="left" VALIGN="top">(<B>no change in beneficial interest</B>) trading the Company&#146;s Securities where the trading results in no change in beneficial interest in the Company&#146;s Securities. However, the requirements of paragraphs 3.3
to 3.7 must be complied with; </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(l)</TD>
<TD ALIGN="left" VALIGN="top">(<B>transfer to SMSF</B>) transferring the Company&#146;s Securities already held into a self-managed superannuation fund in which the Designated Person is a beneficiary; and </TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(m)</TD>
<TD ALIGN="left" VALIGN="top">(<B>subscription under disclosure document</B>) subscribing for the Company&#146;s Securities under a disclosure document. </TD></TR></TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="line-height:1.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000">&nbsp;</P> <P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><B><A NAME="tx411991_6"></A>6.</B></TD>
<TD ALIGN="left" VALIGN="top"><B>Further restrictions </B></TD></TR></TABLE> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>No margin lending </B></P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">6.1</TD>
<TD ALIGN="left" VALIGN="top">Designated Persons are not permitted to enter into margin lending arrangements in relation to the Company&#146;s Securities. This is on the grounds that the terms may require the Company&#146;s Securities to be sold
during a Prohibited Period or when the Designated Person possesses Inside Information. </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">6.2</TD>
<TD ALIGN="left" VALIGN="top">This restriction does not extend to other funding arrangements where the Company&#146;s Securities may be included as security. Designated Persons should consult the Company Secretary if they are uncertain as to whether
an arrangement should be classified as a margin lending arrangement. </TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">7 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>No short term or speculative trading </B></P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">6.3</TD>
<TD ALIGN="left" VALIGN="top">The Company encourages Designated Persons to be long term investors in the Company. </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">6.4</TD>
<TD ALIGN="left" VALIGN="top">Designated Persons must not engage in short term or speculative trading in the Company&#146;s Securities or in financial products associated with the Company&#146;s Securities. Short term means in less than a six month
period. </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">6.5</TD>
<TD ALIGN="left" VALIGN="top">Designated Persons are not permitted to engage in short selling of the Company&#146;s Securities. </TD></TR></TABLE> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>No
hedging </B></P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">6.6</TD>
<TD ALIGN="left" VALIGN="top">Subject to the law, Designated Persons must not: </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(a)</TD>
<TD ALIGN="left" VALIGN="top">enter into transactions or arrangements with anyone which could have the effect of limiting their exposure to risk relating to an element of their remuneration that: </TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="8%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(i)</TD>
<TD ALIGN="left" VALIGN="top">has not vested; or </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="8%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(ii)</TD>
<TD ALIGN="left" VALIGN="top">has vested but remains subject to a holding lock; or </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(b)</TD>
<TD ALIGN="left" VALIGN="top">deal at any time in financial products associated with the Company&#146;s Securities, except for the type of dealing permitted by law or under part 5. </TD></TR></TABLE>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Meaning of financial products </B></P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">6.7</TD>
<TD ALIGN="left" VALIGN="top">For the purposes of this part, financial products includes derivatives, options, warrants, futures, forward contracts, swaps and contracts for difference issued or created over or associated with the Company&#146;s
Securities by third parties. </TD></TR></TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="line-height:1.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000">&nbsp;</P>
<P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><B><A NAME="tx411991_7"></A>7.</B></TD>
<TD ALIGN="left" VALIGN="top"><B>Confidential Information </B></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">7.1</TD>
<TD ALIGN="left" VALIGN="top">You must treat all sensitive, <FONT STYLE="white-space:nowrap">non-public</FONT> information (&#147;<B>Confidential Information</B>&#148;) about the Company as confidential and belonging to the Company. You must not
disclose Confidential Information to others (including family members, relatives, business or social acquaintances) except as authorised or legally required. You must avoid inadvertent or indirect disclosure of Confidential Information.
</TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">7.2</TD>
<TD ALIGN="left" VALIGN="top">Even within the Company, Confidential Information should be distributed to or discussed with others only on a <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">need-to-know</FONT></FONT> basis, and those
people must be told that the information is confidential. Be careful that your conversations are not overheard in elevators, aeroplanes or other public places. Do not leave Confidential Information on conference tables, desks or otherwise unguarded.
</TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">7.3</TD>
<TD ALIGN="left" VALIGN="top">Take whatever steps are reasonably necessary to keep Confidential Information from being disclosed, except as authorised or legally required. </TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">8 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="line-height:1.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000">&nbsp;</P> <P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><B><A NAME="tx411991_8"></A>8.</B></TD>
<TD ALIGN="left" VALIGN="top"><B>Review and publication of this policy </B></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">8.1</TD>
<TD ALIGN="left" VALIGN="top">The Board will review this policy from time to time. The policy may be amended by resolution of the Board. </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">8.2</TD>
<TD ALIGN="left" VALIGN="top">This policy is available on the Company&#146;s website and the key features are published in the annual report or a link to the governance section of the website provided. </TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">9 </P>

</BODY></HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>2
<FILENAME>g411991g0609170443750.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g411991g0609170443750.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" !. -T# 2(  A$! Q$!_\0
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MLWQ5X2LO%MI!;7D\\*PN74PD DD8[@U8\-^'K;PQI"Z;:2RRQ*[.&E(+9/T
/J];G U1]E=-\]]NEC__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>3
<FILENAME>g411991txpg3a.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g411991txpg3a.jpg
M_]C_X  02D9)1@ ! @  9 !D  #_[  11'5C:WD  0 $    9   _^X #D%D
M;V)E &3      ?_; (0  0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0(" @(" @(" @(" P,# P,# P,# P$! 0$! 0$" 0$"
M @(! @(# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,#
M P,# P,# P,#_\  $0@ C +& P$1  (1 0,1 ?_$ -,  0 !! ,! 0
M       % 08'" (#! D* 0$  04! 0$!            !0$" P0&!P@)"A
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M,6Y3M79;YWDJU\EDN*M5?0MZV^0LZD]]%3IW*C^$WIYP:V[.;=M>K+UH?/\
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M;YCR*;42G7AJD@@Z>0\: N.@% 5'0?1]L4 /2?2?EH"E * 4 H!0"@% * 4
MH!0"@/!<KI;K/&5+NDQF''3KHIU8"G% 'L,MC5;RSIP"035T(2N.D%5F&_D6
M,:'/D24(]O3W+I,'Y+NO,E=Y$QUI4".>9)N+X29K@\BF&^TW&'43S+]%2-K#
M4?6N.K[#E,[S!<NIV\-<L.#DUKZ.HPO<WGI#,MY]UQ]YU*E.//+4XZXHD:E;
MBR5*/PUNI**I%41SDG*4G.;;D^+;J6,>D^D_+0H4H!0"@% * 4 H!0"@% *
M4 H"H)&GF.HZP>L'I% 9%QK<F\V,-QIA-VMR=$AF0X1)80-!I'DGF5H!T)7S
M#T5JW<6W<UCZLB9P=[R<.D+E;ME=#>J78S/=ARFRY&SSVV4"^E(+T)XI:ELZ
M_A,E1+B=?OD%2?/4=<L7+7MK0Z_$S\;-5;,M>IZ-%P?9\736+CJ;HH!0"@%
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M@Y$K4G2BFDZPN1_<N0<9P_=DC8NWL*C16VU#19YEK'4IS3A\"=!6R<X>R@%
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M&<4!)VD$RM=#H&U:^;70#XR* N6@% 5'0?1]L4 /2?2?EH"E * 4 H!0"@%
M* 4 H#K>_(O_ *![]4NJKBN\MG[$OLOZ#2*I\\L% * I0'DE06)0U6"%@=EQ
M.@4/,1IHI/IH"VY5O?CZGE"V]?RB.('F4GB4>N@/ 4E/3IQH"E * 4 H!0"@
M% * 4 H!0"@% * 4!M-MI_!MM_3S_P#./5$YGX\O1]!W^Q_VNWWR^\R^ZU26
M/C5_._\ "C?O$;X2/W\PQ=VEYEX:[G=MS6,6A.2'HN48;-MS-OSUH6QLJ1)O
MN/V:(BXPW DNAF/)9'!ZN6\V[=/-V[Q[57=L/FIUQ>DM.M+5/B?4W^)7Q%PO
M)/Q'>R;HK4=MWVW#&\627-:OQDY6*2?"%R;=J<>'-*W+]4_#Q&=1->C1H)]^
MES7F(T&'#TDRILJ4XAF+%B,-E3DB3*><2AM"02M:@!Q->4<REI'5OHZS]9)Q
M=J$KEWU;<$W)NJ44E5MM\$DFV^A'ZS,)\0^2?R@M@]B_"WCN.8[N/OE><?G;
MU>("!F=YOCMFVQR7<GW.X6+;VPPK1-83!N%KL["3-1P;4Z._Y>:055]3_#7X
M=>^;%XVY7+MN+EIRTUD_:]I/U8Z1TXRJ?S3?Y\?YJK#^-U['\DX.#FQMV8VW
M*[SQ4;%NL<=OPVI.[>]>]ZS?)8E9C2AN]X#?YL5Z\3F]:=F=W,+P? 9N2V26
M_MY<\7FWE3=VR:V:RY>-W%-[F2A[Q<;4''(?=<JE.L*;(45ITZ'S1Y$M[+MW
MYC@7+EV$)I7%)*L8O127+3@^-:Z'@OP/_P I,SXD^<O_ !#S5AX>#?R;+>+.
MS*;4[T/6=F2N2?K3@I.W2C<HN-'S*GVS(TKS?BJGV3T5*4 H!0"@% * 4 H!
M0"@% 1ERZ&?2OY$T!%4 H!0"@/$Y\]7IH#A0"@,37/\ :,__ !DC]8JM^'LK
MN.:O_P!3/O?TGAJ\QB@(F_\ [#NW^GROU1J^U[:]'TFGG_T5[^4_H9KU4J<&
M* 4 H!0"@% * 4 H!0"@% * 4!<N.Y=?,9<U@2>\BE96Y;Y.KD-W7YQ[O4%I
M9_"04GKUZ*P7<>W=6NDB2P-US-NE7'E6VWK%ZQ?Z'VJE#-]LW.QJZLQH]PDL
M6*XR9#,=F-<'VVV)4I:7%(9ARW"AMQQ8;/*A7*LD< :CKF)>A7E3E%+6AV6+
MYCV_*487YQM7Y.BC)T3;X*+>C;IP+V^/X?C^W6OH3B=2X;-^0>_2I_$K!<]K
MT&U8]E]Y, $G0 D]0XFK#.2T:U.+T5():0?O  7#Y?*=$?#QH"<:9:83R-("
M4\-?*2=.DD\30';0"@*CH/H^V* 'I/I/RT!2@% * 4 H!0"@% 1MWO%JL%O?
MNM[N,.U6V,DJ?FSY#<:.@ :\H6XH%QP^1"05*\@-7PMSNRY+:;GU&#)RL;"L
M/)R[D+=B/&4G1?\ 'N6IJM??%]BT"\>YV/&KE?K0T[W<B[KE-VMQT<W*MRWV
M]UAYQUO3BDNJ:*NH5*0V:[*-9S49]7Z6>>9?Q*V^SD^'B8\[V,GK-OD;^RFG
MIU5:KV&?L.W'P_<.UO3,7N[4IU$9U4JUO\L>[P#W2M1+@*470@$Z=XCG;/D5
M6A>QKV/*EU:5X]'RG8[9OFV[WC.[@7%*7+K!^K..G3%Z^G@^@U;J81P8H!0"
M@% /-Y#P/GH")EVME[5;?T3AZ>7YAZ/G(' >D?%0%NR(KT97*Z@CCH%#4H5Y
M>RKHZ/AH#ST H!0"@% * 4 H!0"@% * 4 H#:;;3^#;;^GG_ .<>J)S/QY>C
MZ#O]C_M=OOE]YF0&677UAMI"EJ/D2.CSD]"4^<UJDL8P\0V[.*^&S9'<'>?.
M.[EP,0L;[D"Q!:&U9'D=R/U=CN,,J<T#SE[NLAMI8TT#'>*(*4JJ2V?;+V\;
ME:VVQ[5R6KZ%%:RD_LKYVD<9\0O.^W_#GR=G><=Q;\/#M5A%.DKMZ34;-J&J
M?-.XUPUC%.70?E\C?S:O$/$?CS(NU'A2BOQ7VI481]A[$PN.ZPXEUD1Y;4U$
MEE;*D (=20XD@*&AKV+_ .K_ "M%+EC>YDN*<./7[&GH9^>DO\Z_\@)J4;F9
MB2MRK6+CD--/C%_]SJFM'IP-;?&,9&6;GM^(>/<YUXQ'Q.07MU+!<;I+]\FV
M:^*?19\^VVN,H\J??]M<HB.6]E&@*K28+N@2Z*Z;R\X6,/\ *'&,<C#?A-+A
M*-.:W-=DX4;ZIJ2Z#PKXM<^Y^9%Y]MW)WMK\QQ>;:G)J3MW*^'DXLFDDI8EZ
M,K451?P?!G1*:+9\*V,F\[N6G-I=]N.+X9L@P-Z]PLOLT@1KI8L9P2;#GL1+
M)*(+:,GRZ_*B6:UH.O>3)R>!2E0K-OM]6\"6,HJ>1D_P81>J<IIZM?LPC6<G
MT),T/AEMWO?FJUO5Z_<Q=GV5?F&5D6W2=JSC24U&W+@KU^YR6+*Z;EQ<4F;[
MW'^=UXR94^X2;=:MF[;!DS9C]OMSN#3)SMNAOR''(<%Z:<A:5-<AL*2VMTI3
MWI25:#70<M'X:>7XP49RR7<257SI)OI=.7@^A5/<\C_,[XNSO3N6+6T6[+FW
M&#QI2<8MOEBY>*N9Q32YJ*K5:+@?:JS^-^?N3_+ISKQ8[=IL,#<S"]O+NJ]V
M2XQ%72R8WN?CKD"'=8T^UIE,2)%EDJE)FQFU.H4N)(1VM037D?F#9[FQ;K<P
M;E?"3K!_M0EK'TK5/M7:?H'\(OB+A_%'R)A^:\?DAFR3MY-J+_"R;=%<C1ZJ
M,JJY;KKR3CQU,D;$>(_-\^\/N\=SSV#8K)XB_#K%W$Q;=BQ6Z(XUCPS7%<6G
M99B656>V/2%R3AF?XV[ N<(%T\S3KC85J@FH5H],+5A^)O>'-L*\*&";6VC!
M9_B%\1&R-HWHR_)<KBW-.VNTV"1;-CZLHSFXXW9IK-YOLBY9/D#5NL=F;EQT
MR'RM3LA#3*M:I:-L'FW)W"\5GA*M]NW<W<W#V\\0VP<3(L>M6[[=CVL.TVXV
MUMAR:\0K WN%B[EORK)[%EF,XU<K@RNY0)J&9:8BE.MO**%"J43=$#,_A1WD
MS'=.V[OX=N<JQJW:V)WOS7:G,3CD!5KM%WLR'V<AVRRNWVQ<B6N-&RO;^\0G
M]0M2%O)<*>' '3H!K>]XTMTKKE&[EMVZQ3%LT=R#Q-(\)WA2QV<9-IME\RO;
M[$G+WOSNQN%E$-<N:_MY@TUJ5S-0V$O$0.X0KO'@I-4@7UN(YX\=DL0O>\/_
M %,V?\1%OPNV2<ISG8^V[-S=L+A=<7M#"YV2L;59Q&S7)[@,EMMK9>?@L7B.
M^W.4T&U*;6L4HGHJU!(7OQ*;@;TYI@FU_A%7A##^2[-8?O\ 9UO%N5:KOD&-
M;<;>;BJ=;V]LELPJR7*SR<IW&S 19+S<=^?%A0HD5;KJEE2$FT&6\4M'B/V^
MLVXU\W6WFV_W8MEJP2^WC%6[)LZ=M;U;,CL]MGW(+NC\3-LCM=XL;K<9*0R&
M67PK4EPCIKZO:#%7AGE>+S=G;#8O>O+=]=L!C^XF&8-N'D6#VKP[K@R$VW([
M9"N]PQRW9<O<Z0N,\EJ266YRH2^4@+[H_-JLDD] 8YVC\7NZ5P\8&Y6S>ZT+
M$V=H,AW8W2V?V R>RVUZW76!N%M#:L=R>[8)G$UV8_&N-US##\A7/M+B4,J<
M-N?;"5$\#6E>D&QV#;J93EGB&\3>UUV%K_=C9]>RPQ!46$IBYD;@;?N9-?\
MZWF%]:9Y%R; CZ(;[IKL]KIJE-*@SQ5 * 4 H#Q.?/5Z: X4 H#$US_:,_\
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M6GWIT9GB-$9C#5M.J_*XKBKSZ=0K2.F/5K0"@% * J.@^C[8H >D^D_+0%*
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M$^V$E*B69M]G:+MK>;'BSMV&U=4YSN4M3]6<X\\I<KMJDFUJX\R+O+?FS/\
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M!MOCF.;=7^UYLWC&-W^ZVXY;N9FLS'I-PA8OAN&XTU(EN2ICC7?/AIID+<6
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MN-R2=.+H^)C3I.IXD\23TDGI.OGK;22X'/\ :*J!0"@% * 4 H!0"@% * 4
MH!0"@% * 4!B?>;^$&?]<@?J)M;NW_CO[+^HYGS;_:X_SE]V1JY4R>:GU%\
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M/_-]N_X&FN1\Q_CV_L?\Q]!?!S^T9O\ N8_<1OA7.GKXH!0"@% 5'0?1]L4
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M6V=-%",SJ6XX/6-5^>M.Y>G<T>B.IP]LQ\1J:7-=7ZSZ.[J+LK$2 H!0"@%
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MEG[G\QY4_N3LUJ> X'+\! T)T3Q/17G?DRO_ )C9;X^+>?\ ^,S[ _R/<?\
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M4XXLZ:Z)0D%1]/15KDH\>!?"$[DE&";D^"6IDRS[;/OH#UZDJAZ@$1(I;6^
M>(+SJ@MI!\R0KSFM.[FJ+Y;:J=!B^7YSCSY<G!_LJE?2W7YA>=MGV&R]9I*I
M?*.U$E%#;ZM/(R\GE:<)'D(23UU2UF<SI/1#+V"<(N6))R_=?'T/A\R,!9_@
MN7YG;HF,8SC]QNM[<OL'FA,L*08S:6I:5R)KSO(Q#BM\PYG'%)0.LZBI7%RL
M>Q-W;DDH*+_TCAM^VG<]SQX[?@V9SS/%7JTHTJ2UE711[7H9[V<\%MDQJ1 R
M/="9'R6\1U-RH^,0DJ_=V%(00MOZQD+"';RZPX->0)1')'$+%:.;OT[L7:Q%
MRVW^MTM=G4=3Y7^%F+@2AG;_ "CD9*HU:C^%%\:R?Z[75I%/K-Z^      "0
M$I"4I &B4I2D )2D< /(!7.GKPH!0"@% * J.@^C[8H >D^D_+0%* 4 H!0%
M"0 22 !TDG0#TDT!XG9FFH: )X@+(.G5JD<-=* CU+4L\RU%1ZS0'&@+2R/"
MK%DB%+DQ_=9^G8N,0)1(U'S0^-.22@'\(<W416>UD7+7!UCU$7G;3BYR<I+D
MO]$H\>RJZ3"<_:W*(TP,1&6;A&6KZ.:T^TTA*2>!D-/+#C"@#Q YQU$UOQS+
M+C5Z,Y>YY?W"%QV[24[?1*J7RINID7'MKK7:T>]7E3=WFAM:@SRJ3;V%<I4-
M&U:+DJ2?*OL^S6M<RYS?+#2-?236%Y?L8\?%RWXMVG#]5/LZR$ "0$I 2E(
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MBU>I,UC-PJ.GX#\AH"">_*N_I%_C&@/*_(CQ6^]E/LQF]2.=]U#2#IIT*6H
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MR8X1'O"%3&1HD2VP!*0.MQ)(0^!_W5>FM>YCJ7L:/YB:Q=XN0]3)7-'KZ?\
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M$=!' T!-6^4MQ19<)4>4J0H].@(!23Y>F@):@% * J.@^C[8H >D^D_+0%*
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M)E!ONI#++CP<:[(<+:"K1Q'S5:A/3TU?";3H:.9B6;D)74DKB5:HQG6R<\N
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@7U?A4!/]CVO50#L>UZJ =CVO50%1R:'YW1YNL4!__]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>4
<FILENAME>g411991txpg3b.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g411991txpg3b.jpg
M_]C_X  02D9)1@ ! @  9 !D  #_[  11'5C:WD  0 $    9   _^X #D%D
M;V)E &3      ?_; (0  0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0(" @(" @(" @(" P,# P,# P,# P$! 0$! 0$" 0$"
M @(! @(# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,#
M P,# P,# P,#_\  $0@ .@+& P$1  (1 0,1 ?_$ ,H  0 !!0$! 0$
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M6R<]W&@&NEZV3GNXT UTO6R<]W&@&NEZV3GNXT UTO6R<]W&@&NEZV3GNXT
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ME0O;9]Z.Z^A,HKCTWQJEIH5O%7-.47L;P[3G]RI]O;/B;D=J*1@)&MDJ;BZ
MX;HGBF?"1^DI,)V]3N.#V%%<6_%[1_\ L*X@M;<L-J;7:0?M^^'->[M_[.M^
M?6W<AJ6Q$/\ Y-Q_Y*G\TOK!O]\ )]M7?(,?M*MW/VZ;D-2V(.YN4L?$J?S2
M^L]K; _ALKKW9;-?]I^TC:)L5WMU%=([98IJB)T4-=!'4Q137&OGFTI6QR .
MT( ,<Q.=<[<\9\.I*E1I1QC)K&7,\,ET:S[%P+_&\[RSHWW$;^LHU:<9[E/'
M0I)-)RDWITZ<(]9Z&V>[&.S_ &=,<D-MN%VJH\,*O:"]W6\2:0]V(*BJ%"QQ
M/YL("JJO$;NMH<DHZHI+]O:=_8>C/3W#\)0I2JU%]ZK.<^O!O=_TG5XI98(V
M0PR2111M#(XXWN:QC6C -8T$-:T#, H+TO%YG3QA&$5&*PBEH2T(V6T5%0:>
M7&>8_##/(\^X'G+3/,F4,B7;55+#I,J)VG?;*\'Q.7@WF='>;@SE3NE'GN=C
MS@04!+4=UEJGF,ZQC@W2Q$KBW)GSG$>- 2.NEZV3GNXT UTO6R<]W&@*A++@
M_P"%DY(]V[\YO"@+* ( @" ( @" ( @" ( @.;WSM/L%HGEI*5D]WJ87.9)Z
MJZ..DCD;D+#528ZPAV0Z#7 '=4JG:5*BWGA%<^91W?'[.WDZ=-2JU%JT)=;S
MZD<[N':YM!4:3;?26^VL/)=H/K9P-SRYRV'']FI4;*DN^VWL*:MZCO9Z*,84
MUT;S[='8:+<-I+_=<?:%XKZEKL\1J'QP=P00ZN$#]%28TJ<.[%(J:U[>7'G5
M)R6K'!;%H-9KA_E*CT"3@,IRC',O9%-*0! $ 0! $ 0! $ 0! $ 0! $&9)4
M-YNUL(=;KE6T6!QPIZB6-A]*,.U;N^"O,H0GWDF;J5Q<4/(G.'0VC>+?VJ[4
M4FBVJ-%=(P #ZU (93^VI3$<<-]KE'E9T998HM:/'^(4G]O<J+G6#VK WVU]
MKMGJG,BNE!4VQSL ZHB>*RE:3DQ<&MCJ&,!W0UV"C3LIKN--;"XM_4=O4:C<
M0E!OE7VE[GV,ZM#-#4PQ5-/+'/3SL;)#-$X/CEC<,6O8YI(+2%#::>#S.@A.
M%2"G3:<'DUD7%@]! $ 0&UV8849)W97X<.&KS>! 2J ( @" ( @" ( @" (
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MD2R\&\("4M/TD_%N_*$!LB ("IN9_HCW[4!2@" ( @" ( @" (#Z 2< "3O
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MA98!L9:3++)(=.NQ:T!C3_GJ@9\7.P\"J+OSY?3D.^X%^F0Z9?FD=*CH:2+
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M02 X%E933TSL=X:YC [O8J5&<9K&+3125:%>@]VO"<)?O)KVF&O1J" ( @"
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MFGW,M7QE?_'U*I[OSW].1'?<"_3*?7^:1O:CEN$ 0! $ 0! $ 0! $ 0! $
M0! $ 0! $!3(]D4;I9GLAB;E=+*]L431ONDD+6-'=*+3H69B345O2T17*S0;
MSVJ]GU@<YM=M-033QXXTEL<^Z5)(')#:%LT;7>DYJE4[*YJ]V#PY]'M*:Z]0
M\%M&XU;B#FN2/VW_ *<5M9JE5VG4$S6SVVVU4S:A@GB=7.;2>1,-8S2A9KI
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M^G25EQZ?X1<Z945">N#W>Q:.PYO=.P.G=I/LFT$L60EM/=:5LS<=P>M4AC<
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M+S'H^%5\.OJ.ON_+7E9?>SZCFLO+=T>?]3T?Z/ I*R.?EWGEGR9=1;63 0!
M7:;IV=/RA]%^D;G1^=O+#R/4.^L^K/J.[;+_ $5OWCY/^\]%^R4"KWON]1UM
MAY?]?^/W&UK26(0$1M%]FR?8/(=]Y_L[-^5;*7>^]_#F1;[R'Y/^[W#Q+M;]
MJ3?=;EN^ZWT//N\*OZ/=^_\ Q'RCB/S#^7S?D]TU9;RO" ( @ SK#R,K,[UV
M=?=MO1_3ZOH^5RF]+YWYOFX*JO?.Y?=U':\!_3E^.7MY?=S&]#..[NYN^H9<
M&U6CDC[+_1^D[GC7B63SS+.TR_I]69LIS[O?SK46!\0! $!6S/WO[P@+J (
<@).V=.[XIV;TV<K^Y 3J ( @*FYG^B/?M0'_V0$!

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
